Conclusions and Implications
These results identify CBD3063, as a selective, first-in-class,
CRMP2-based peptidomimetic, which allosterically regulates
Cav2.2 to achieve analgesia.
Keywords: Cav2.2, CRMP2, Peptidomimetics,
Molecular Dynamics Simulations, Chronic Pain.